Amazon launched a GLP-1 weight loss program on April 21, 2026, integrating obesity treatment into its Amazon One Medical primary care service with virtual visits, prescription management, and pharmacy fulfillment.
The program positions weight management as a chronic condition rather than a one-time prescription, aiming to improve long-term adherence through reliable delivery and transparent pricing.
Through Amazon Pharmacy, patients can access Novo Nordisk’s Wegovy and Eli Lilly’s Zepbound, with insured pricing starting at $25 per month and cash-pay options beginning at $149 for oral drugs and $299 for injectables.
Amazon emphasized same-day delivery convenience, planning to expand its pharmacy delivery network to 4,500 cities by the end of 2026, leveraging its logistics infrastructure to differentiate in a competitive market.
The company will offer on-demand prescription renewals starting at $29 for message consultations and $49 for video visits, lowering barriers to ongoing care access.
Shares of competitors like Hims & Hers Health, Viking Therapeutics, Amgen, and Septerna declined following the announcement, signaling market concern over Amazon’s entry into the high-growth obesity drug space.
Amazon’s move reflects its broader strategy of using scale and convenience to disrupt traditional healthcare delivery, particularly in chronic disease management where adherence and access remain key challenges.
By embedding GLP-1 access within primary care, Amazon aims to capture patients earlier in their treatment journey and retain them through integrated pharmacy and care coordination services.
How does Amazon’s pricing compare to existing market rates for GLP-1 medications?
Amazon said its insured pricing starting at $25 per month and cash-pay rates for oral drugs at $149 and injectables at $299 are roughly in line with much of the current market.
What is Amazon’s goal for same-day pharmacy delivery expansion by the end of 2026?
Amazon plans to expand its same-day drug delivery offering to 4,500 cities by the end of 2026.
